Neuraly's Unattributed Round

Neuraly raised a round of funding on April 17, 2018.

Neuraly, a biotech company founded on technology created at the Johns Hopkins School of Medicine, is focused on the development of neuroprotective agents for neurologic disorders such as Alzheimer's d…

Articles about Neuraly's Unattributed Round: